Journal article

Dual HER2 Blockade

Christoph Thomssen, Nagi S El Saghir, Prudence A Francis, Jacek Jassem, Hope S Rugo, Michael Untch

Breast Care | KARGER | Published : 2017

DOI: 10.1159/000484226

Keywords

Multicenter
Obstetrics & Gynecology
Science & Technology
Lapatinib
Her2-Positive Breast-Cancer
Life Sciences & Biomedicine
Trastuzumab
Therapy
Open-Label
Oncology
Phase-3 Trial